These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 28668232)

  • 1. Effect of Salbutamol on Respiratory Muscle Strength in Spinal Muscular Atrophy.
    Khirani S; Dabaj I; Amaddeo A; Olmo Arroyo J; Ropers J; Tirolien S; Coudert V; Estournet B; Fauroux B; Quijano-Roy S
    Pediatr Neurol; 2017 Aug; 73():78-87.e1. PubMed ID: 28668232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of respiratory muscles and motor function in children with SMA treated by nusinersen.
    Gómez-García de la Banda M; Amaddeo A; Khirani S; Pruvost S; Barnerias C; Dabaj I; Bénézit A; Durigneux J; Carlier RY; Desguerre I; Quijano-Roy S; Fauroux B
    Pediatr Pulmonol; 2021 Jan; 56(1):299-306. PubMed ID: 33118682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal course of lung function and respiratory muscle strength in spinal muscular atrophy type 2 and 3.
    Khirani S; Colella M; Caldarelli V; Aubertin G; Boulé M; Forin V; Ramirez A; Fauroux B
    Eur J Paediatr Neurol; 2013 Nov; 17(6):552-60. PubMed ID: 23672834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cough, sniff and maximal static pressure patterns in spinal muscular atrophy.
    Khirani S; Amaddeo A; Fauroux B
    Respir Physiol Neurobiol; 2020 Jan; 271():103308. PubMed ID: 31561013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural history of respiratory muscle strength in spinal muscular atrophy: a prospective national cohort study.
    Veldhoen ES; Wijngaarde CA; Hulzebos EHJ; Wösten-van Asperen RM; Wadman RI; van Eijk RPA; Asselman FL; Stam M; Otto LAM; Cuppen I; Scheijmans FEV; den Oudenrijn LPV; Bartels B; Gaytant MA; van der Ent CK; van der Pol WL
    Orphanet J Rare Dis; 2022 Feb; 17(1):70. PubMed ID: 35189949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spontaneous Breathing Pattern as Respiratory Functional Outcome in Children with Spinal Muscular Atrophy (SMA).
    LoMauro A; Aliverti A; Mastella C; Arnoldi MT; Banfi P; Baranello G
    PLoS One; 2016; 11(11):e0165818. PubMed ID: 27820869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of salbutamol in treatment of children with later-onset spinal muscular atrophy.
    Feng Y; Jin J; Chen T; Wang J; Jiang Y; Gao F; Mao S
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2023 Dec; 52(6):714-720. PubMed ID: 38105669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations of thoraco-abdominal volumes and asynchronies in patients with spinal muscle atrophy type III.
    LoMauro A; Romei M; Priori R; Laviola M; D'Angelo MG; Aliverti A
    Respir Physiol Neurobiol; 2014 Jun; 197():1-8. PubMed ID: 24632504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiographic and Respiratory Effects of Growing Rods in Children With Spinal Muscular Atrophy.
    Lenhart RL; Youlo S; Schroth MK; Noonan KJ; McCarthy J; Mann D; Hetzel S; Sund SA; Halanski MA
    J Pediatr Orthop; 2017 Dec; 37(8):e500-e504. PubMed ID: 27636914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Muscle strength and motor function throughout life in a cross-sectional cohort of 180 patients with spinal muscular atrophy types 1c-4.
    Wadman RI; Wijngaarde CA; Stam M; Bartels B; Otto LAM; Lemmink HH; Schoenmakers MAGC; Cuppen I; van den Berg LH; van der Pol WL
    Eur J Neurol; 2018 Mar; 25(3):512-518. PubMed ID: 29194869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Respiratory management of children with spinal muscular atrophy (SMA).
    Fauroux B; Griffon L; Amaddeo A; Stremler N; Mazenq J; Khirani S; Baravalle-Einaudi M
    Arch Pediatr; 2020 Dec; 27(7S):7S29-7S34. PubMed ID: 33357594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Respiratory muscle fatigability in patients with spinal muscular atrophy.
    Kant-Smits K; Hulzebos EHJ; Habets LE; Asselman FL; Veldhoen ES; van Eijk RPA; de Groot JF; van der Pol WL; Bartels B
    Pediatr Pulmonol; 2022 Dec; 57(12):3050-3059. PubMed ID: 36039838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salbutamol tolerability and efficacy in patients with spinal muscular atrophy type II.
    Frongia AL; Natera-de Benito D; Ortez C; Alarcón M; Borrás A; Medina J; Vigo M; Padrós N; Moya O; Armas J; Carrera-García L; Expósito-Escudero J; Cuadras D; Bernal S; Martorell L; Colomer J; Nascimento A
    Neuromuscul Disord; 2019 Jul; 29(7):517-524. PubMed ID: 31201046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perceived efficacy of salbutamol by persons with spinal muscular atrophy: A mixed methods study.
    Giovannetti AM; Pasanisi MB; Černiauskaitė M; Bussolino C; Leonardi M; Morandi L
    Muscle Nerve; 2016 Nov; 54(5):843-849. PubMed ID: 26970407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of salbutamol on skeletal muscle in chronic heart failure.
    Harrington D; Chua TP; Coats AJ
    Int J Cardiol; 2000 May; 73(3):257-65. PubMed ID: 10841968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sniff nasal inspiratory pressure and sleep disordered breathing in childhood neuromuscular disorders.
    Anderson VB; McKenzie JA; Seton C; Fitzgerald DA; Webster RI; North KN; Joffe DA; Young HK
    Neuromuscul Disord; 2012 Jun; 22(6):528-33. PubMed ID: 22386707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Daily salbutamol in young patients with SMA type II.
    Pane M; Staccioli S; Messina S; D'Amico A; Pelliccioni M; Mazzone ES; Cuttini M; Alfieri P; Battini R; Main M; Muntoni F; Bertini E; Villanova M; Mercuri E
    Neuromuscul Disord; 2008 Jul; 18(7):536-40. PubMed ID: 18579379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Respiratory muscle function in infants with spinal muscular atrophy type I.
    Finkel RS; Weiner DJ; Mayer OH; McDonough JM; Panitch HB
    Pediatr Pulmonol; 2014 Dec; 49(12):1234-42. PubMed ID: 24777943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between respiratory function and need for NIV in childhood SMA.
    Kapur N; Deegan S; Parakh A; Gauld L
    Pediatr Pulmonol; 2019 Nov; 54(11):1774-1780. PubMed ID: 31328439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SMA CARNIVAL TRIAL PART II: a prospective, single-armed trial of L-carnitine and valproic acid in ambulatory children with spinal muscular atrophy.
    Kissel JT; Scott CB; Reyna SP; Crawford TO; Simard LR; Krosschell KJ; Acsadi G; Elsheik B; Schroth MK; D'Anjou G; LaSalle B; Prior TW; Sorenson S; Maczulski JA; Bromberg MB; Chan GM; Swoboda KJ;
    PLoS One; 2011; 6(7):e21296. PubMed ID: 21754985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.